Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV
Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV
批准号:
422724
负责人:
Woodside Michael T
金额:
$21.6万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-02-01 至 2022-02-01
中文摘要
新型冠状病毒2019-nCoV在过去3个月里迅速传播,感染了数十个国家的数万人,导致1000多人死亡,没有预防性疫苗或药物可以治疗它。我们建议寻找可能的药物
英文摘要
The new coronavirus 2019-nCoV has spread rapidly in the last 3 months, infecting tens of thousands of people in dozens of countries and killing over 1,000, with no preventive vaccines or medications that can treat it. We propose to search for possible dru
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using engineered heterodimers to probe prion-like propagation of misfolding in SOD1
-
批准号:469944
-
项目类别:Operating Grants
-
资助金额:$69.66万
-
财政年份:2022
-
负责人:Woodside Michael T
-
依托单位:
Probing the role of mechanical rigidity in viral xrRNAs as the key to preventing their degradation by host RNases
-
批准号:462068
-
项目类别:Operating Grants
-
资助金额:$68.55万
-
财政年份:2022
-
负责人:Woodside Michael T
-
依托单位:
COVID-19 Variant Supplement - Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV
-
批准号:443173
-
项目类别:Operating Grants
-
资助金额:$3.64万
-
财政年份:2021
-
负责人:Woodside Michael T
-
依托单位:
The role of mRNA conformational dynamics in stimulating translational recoding
-
批准号:320554
-
项目类别:Operating Grants
-
资助金额:$53.99万
-
财政年份:2015
-
负责人:Woodside Michael T
-
依托单位:
海外基金